Matthew J Ellis Selected Research

Matthew J Ellis Research Topics

Disease

173	Breast Neoplasms (Breast Cancer) 01/2024 - 05/2002
120	Neoplasms (Cancer) 02/2024 - 05/2002
17	Triple Negative Breast Neoplasms 01/2023 - 01/2010
10	Pathologic Complete Response 01/2024 - 03/2009
10	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2004
7	Disease Progression 02/2024 - 07/2006
3	Carcinogenesis 11/2020 - 01/2014
3	Carcinoma (Carcinomatosis) 01/2020 - 08/2005
3	Osteoporosis 07/2017 - 04/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2023
2	Hypersensitivity (Allergy) 01/2021 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 10/2014
2	Metabolic Bone Diseases (Osteopenia) 07/2017 - 04/2013
2	Fatigue 04/2016 - 04/2009
2	Diarrhea 04/2016 - 04/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2024
1	Residual Neoplasm 01/2024

Drug/Important Bio-Agent (IBA)

73	Estrogen ReceptorsIBA 01/2024 - 08/2003
36	Aromatase InhibitorsIBA 04/2023 - 08/2003
36	Hormones (Hormone)IBA 10/2021 - 08/2003
29	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2009
26	Anastrozole (Arimidex)FDA LinkGeneric 01/2024 - 12/2006
23	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2003
21	Phenobarbital (Luminal)FDA Link 01/2024 - 08/2007
21	Estrogens (Estrogen)FDA Link 01/2021 - 08/2003
20	Letrozole (Femara)FDA LinkGeneric 04/2023 - 05/2002
18	Tamoxifen FDA LinkGeneric 01/2020 - 05/2002
17	Fulvestrant (Faslodex)FDA Link 01/2024 - 09/2009
14	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 08/2007
13	RNA (Ribonucleic Acid)IBA 01/2024 - 12/2009
13	exemestane (Aromasin)FDA Link 04/2023 - 12/2006
13	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 08/2003
12	Trastuzumab (Herceptin)FDA Link 10/2023 - 01/2004
9	Phosphotransferases (Kinase)IBA 01/2023 - 01/2004
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 05/2004
7	AnthracyclinesIBA 09/2023 - 10/2007
7	ErbB Receptors (EGF Receptor)IBA 08/2021 - 08/2005
7	Estradiol (Delestrogen)FDA LinkGeneric 01/2020 - 08/2009
6	ProteomeIBA 10/2023 - 12/2013
5	Messenger RNA (mRNA)IBA 02/2024 - 01/2017
5	Estrogen Receptor alphaIBA 12/2021 - 05/2004
5	Peptides (Polypeptides)IBA 03/2016 - 08/2003
5	ParaffinIBA 11/2015 - 11/2010
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013 - 05/2004
4	taxaneIBA 09/2023 - 03/2009
4	neratinibIBA 01/2022 - 04/2009
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 11/2015
4	Aromatase (CYP19)IBA 01/2020 - 07/2009
4	palbociclibIBA 01/2020 - 11/2015
4	Formaldehyde (Formol)FDA Link 08/2015 - 11/2010
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 12/2014
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 04/2009
3	LigandsIBA 12/2021 - 09/2011
3	NVP-BKM120IBA 12/2020 - 03/2011
3	Long Noncoding RNAIBA 12/2018 - 01/2014
3	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 04/2005
3	MK 2206IBA 11/2017 - 08/2013
3	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2013 - 08/2004
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2013 - 10/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2011 - 05/2004
2	Interleukin-6 (Interleukin 6)IBA 02/2024 - 12/2014
2	Protein Kinases (Protein Kinase)IBA 01/2024 - 01/2005
2	Antiviral Agents (Antivirals)IBA 11/2023 - 01/2021
2	P-2 (P 2)IBA 09/2023 - 03/2009
2	APTIBA 01/2023 - 06/2015
2	Neurofibromin 1 (Neurofibromin)IBA 01/2023 - 01/2020
2	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2020
2	Docetaxel (Taxotere)FDA Link 11/2022 - 08/2021
2	Carboplatin (JM8)FDA LinkGeneric 11/2022 - 08/2021
2	Everolimus FDA Link 01/2021 - 03/2011
2	CateninsIBA 01/2020 - 02/2016
2	AntigensIBA 01/2020 - 01/2018
2	human ERBB2 proteinIBA 07/2018 - 04/2012
2	MA 12 (MA12)IBA 01/2018 - 08/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 08/2004
2	CytokinesIBA 01/2018 - 12/2014
2	Goserelin (Zoladex)FDA Link 11/2017 - 08/2017
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2015 - 04/2012
2	AntibodiesIBA 10/2014 - 08/2011
2	Fluorouracil (Carac)FDA LinkGeneric 12/2013 - 04/2012
2	Epirubicin (Ellence)FDA LinkGeneric 12/2013 - 04/2012
2	temsirolimus FDA Link 05/2013 - 11/2012
2	TOR Serine-Threonine KinasesIBA 05/2013 - 03/2011
2	thiamine triphosphorate (TTP)IBA 11/2012 - 03/2007
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2012 - 06/2011
2	Lapatinib (GW572016)FDA Link 08/2005 - 04/2005
2	LipidsIBA 08/2004 - 08/2003
1	C188-9 compoundIBA 02/2024

Therapy/Procedure

111	Therapeutics 01/2024 - 01/2003
25	Drug Therapy (Chemotherapy) 09/2023 - 01/2004
13	Neoadjuvant Therapy 01/2024 - 04/2004
13	Adjuvant Chemotherapy 01/2021 - 05/2004
3	Transplantation 11/2023 - 09/2006
3	Immunotherapy 01/2020 - 01/2017
3	Segmental Mastectomy (Lumpectomy) 06/2011 - 01/2007
2	Combination Drug Therapy (Combination Chemotherapy) 11/2022 - 04/2004
2	Precision Medicine 12/2021 - 01/2016
2	Catheters 01/2021 - 07/2013
2	Aftercare (After-Treatment) 12/2017 - 06/2011
2	Chemoprevention 11/2004 - 05/2002